Kestra Medical Financials

KMTS Stock   26.92  0.54  1.97%   
Kestra Medical Technologies may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Kestra Medical's Non Current Liabilities Total is comparatively stable compared to the past year. Other Current Assets is likely to gain to about 3.7 M in 2026, whereas Other Current Liabilities is likely to drop slightly above 8 M in 2026.
 
Covid
 
Interest Hikes

Kestra Medical Balance Sheet Chart

At this time, Kestra Medical's Non Current Liabilities Total is comparatively stable compared to the past year. Other Current Assets is likely to gain to about 3.7 M in 2026, whereas Other Current Liabilities is likely to drop slightly above 8 M in 2026.
Key indicators impacting Kestra Medical's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio6.356.05
Sufficiently Up
Slightly volatile
The financial analysis of Kestra Medical is a critical element in measuring its lifeblood. Investors should carefully consider Kestra Medical's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

(107.55 Million)

  
Build AI portfolio with Kestra Stock
Please note, the imprecision that can be found in Kestra Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Kestra Medical Technologies. Check Kestra Medical's Beneish M Score to see the likelihood of Kestra Medical's management manipulating its earnings.

Kestra Medical Stock Summary

Kestra Medical competes with Azenta, Novocure, STAAR Surgical, BioLife Solutions, and Wave Life. Kestra Medical is entity of United States. It is traded as Stock on NASDAQ exchange.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINBMG524411052
Business Address3933 Lake Washington
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitekestramedical.com
Phone425 279 8002

Kestra Medical Key Financial Ratios

Kestra Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Kestra Medical's current stock value. Our valuation model uses many indicators to compare Kestra Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kestra Medical competition to find correlations between indicators driving Kestra Medical's intrinsic value. More Info.
Kestra Medical Technologies is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Kestra Medical's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Kestra Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Most indicators from Kestra Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kestra Medical Techn current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kestra Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
At this time, Kestra Medical's Selling General Administrative is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 385.4 M in 2026, whereas Enterprise Value Over EBITDA is likely to drop (9.63) in 2026.
 2023 2024 2025 2026 (projected)
Reconciled Depreciation11.6M8.0M9.2M5.6M
Total Operating Expenses85.4M130.6M150.2M76.5M

Kestra Medical fundamental ratios Correlations

0.690.80.680.80.92-0.95-0.870.91.00.910.691.0-0.790.780.91.00.390.890.931.00.990.98-0.110.990.79
0.690.950.970.160.88-0.47-0.920.810.630.890.970.63-0.40.90.530.670.870.310.860.640.610.550.420.610.71
0.80.950.960.370.92-0.66-0.940.860.770.920.960.77-0.430.90.630.790.740.50.910.770.750.70.290.750.8
0.680.970.960.160.87-0.48-0.910.790.620.880.990.62-0.370.80.430.670.860.310.850.630.610.540.50.610.67
0.80.160.370.160.5-0.93-0.420.50.850.490.190.85-0.680.40.80.81-0.230.990.530.840.860.9-0.430.860.47
0.920.880.920.870.5-0.76-0.990.980.881.00.860.88-0.70.860.780.910.720.631.00.890.880.830.110.880.85
-0.95-0.47-0.66-0.48-0.93-0.760.72-0.75-0.97-0.75-0.49-0.970.68-0.65-0.89-0.95-0.12-0.97-0.78-0.96-0.97-0.980.29-0.97-0.71
-0.87-0.92-0.94-0.91-0.42-0.990.72-0.95-0.83-0.99-0.9-0.830.59-0.87-0.72-0.86-0.77-0.56-0.98-0.84-0.82-0.78-0.19-0.82-0.83
0.90.810.860.790.50.98-0.75-0.950.860.970.760.86-0.690.850.830.890.690.620.980.870.860.82-0.070.860.92
1.00.630.770.620.850.88-0.97-0.830.860.880.641.0-0.80.750.911.00.320.920.91.01.00.99-0.151.00.76
0.910.890.920.880.491.0-0.75-0.990.970.880.870.88-0.70.860.760.910.740.621.00.880.870.820.140.870.84
0.690.970.960.990.190.86-0.49-0.90.760.640.870.64-0.380.810.440.680.820.340.840.650.620.560.530.620.63
1.00.630.770.620.850.88-0.97-0.830.861.00.880.64-0.80.750.911.00.320.920.91.01.00.99-0.151.00.76
-0.79-0.4-0.43-0.37-0.68-0.70.680.59-0.69-0.8-0.7-0.38-0.8-0.45-0.73-0.81-0.26-0.73-0.72-0.8-0.8-0.790.13-0.8-0.48
0.780.90.90.80.40.86-0.65-0.870.850.750.860.810.75-0.450.790.770.650.530.860.760.730.710.030.730.84
0.90.530.630.430.80.78-0.89-0.720.830.910.760.440.91-0.730.790.90.240.850.80.910.90.92-0.450.90.82
1.00.670.790.670.810.91-0.95-0.860.891.00.910.681.0-0.810.770.90.380.890.921.01.00.98-0.111.00.78
0.390.870.740.86-0.230.72-0.12-0.770.690.320.740.820.32-0.260.650.240.38-0.070.70.330.30.230.490.30.56
0.890.310.50.310.990.63-0.97-0.560.620.920.620.340.92-0.730.530.850.89-0.070.660.920.930.95-0.340.930.56
0.930.860.910.850.531.0-0.78-0.980.980.91.00.840.9-0.720.860.80.920.70.660.90.890.850.060.890.86
1.00.640.770.630.840.89-0.96-0.840.871.00.880.651.0-0.80.760.911.00.330.920.91.00.99-0.141.00.77
0.990.610.750.610.860.88-0.97-0.820.861.00.870.621.0-0.80.730.91.00.30.930.891.01.0-0.171.00.77
0.980.550.70.540.90.83-0.98-0.780.820.990.820.560.99-0.790.710.920.980.230.950.850.991.0-0.241.00.75
-0.110.420.290.5-0.430.110.29-0.19-0.07-0.150.140.53-0.150.130.03-0.45-0.110.49-0.340.06-0.14-0.17-0.24-0.17-0.3
0.990.610.750.610.860.88-0.97-0.820.861.00.870.621.0-0.80.730.91.00.30.930.891.01.01.0-0.170.77
0.790.710.80.670.470.85-0.71-0.830.920.760.840.630.76-0.480.840.820.780.560.560.860.770.770.75-0.30.77
Click cells to compare fundamentals

Kestra Medical Account Relationship Matchups

Today, most investors in Kestra Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Kestra Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Kestra Medical growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.0653)

At this time, Kestra Medical's Price Earnings To Growth Ratio is comparatively stable compared to the past year.

Kestra Medical February 14, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Kestra Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kestra Medical Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kestra Medical Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Kestra Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kestra Medical's daily price indicators and compare them against related drivers.

Additional Tools for Kestra Stock Analysis

When running Kestra Medical's price analysis, check to measure Kestra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kestra Medical is operating at the current time. Most of Kestra Medical's value examination focuses on studying past and present price action to predict the probability of Kestra Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kestra Medical's price. Additionally, you may evaluate how the addition of Kestra Medical to your portfolios can decrease your overall portfolio volatility.